Pnc Financial Services Group, Inc. Mirati Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

$150 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$41.99 - $62.38 $125 - $187	3 Added 1.26%	242 $14,000
Q3 2023 Nov 13, 2023	BUY	$27.8 - $45.35 $2,863 - $4,671	103 Added 75.74%	239 $10,000
Q2 2023 Aug 11, 2023	BUY	$36.13 - $49.49 $650 - $890	18 Added 15.25%	136 $4,000
Q1 2023 May 15, 2023	SELL	$36.54 - $54.26 $328 - $488	-9 Reduced 7.09%	118 $4,000
Q4 2022 Feb 10, 2023	SELL	$41.27 - $98.62 $9,904 - $23,668	-240 Reduced 65.4%	127 $5,000
Q3 2022 Nov 10, 2022	BUY	$59.5 - $86.7 $12,554 - $18,293	211 Added 135.26%	367 $25,000
Q2 2022 Aug 12, 2022	SELL	$39.16 - $88.71 $3,485 - $7,895	-89 Reduced 36.33%	156 $10,000
Q1 2022 May 12, 2022	BUY	$75.82 - $150.97 $14,557 - $28,986	192 Added 362.26%	245 $20,000
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $3,300 - $4,757	-25 Reduced 32.05%	53 $7,000
Q3 2021 Nov 05, 2021	BUY	$132.13 - $177.45 $3,567 - $4,791	27 Added 52.94%	78 $13,000
Q2 2021 Aug 06, 2021	BUY	$144.0 - $179.73 $3,024 - $3,774	21 Added 70.0%	51 $8,000
Q1 2021 May 07, 2021	BUY	$158.92 - $221.61 $2,224 - $3,102	14 Added 87.5%	30 $5,000
Q4 2020 Feb 12, 2021	BUY	$162.05 - $240.27 $2,592 - $3,844	16 New	16 $3,000
Q3 2020 Nov 06, 2020	SELL	$113.26 - $167.27 $58,555 - $86,478	-517 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$72.01 - $120.39 $1.38 Million - $2.3 Million	-19,140 Reduced 97.37%	517 $59,000
Q1 2020 May 08, 2020	BUY	$69.78 - $116.21 $327,547 - $545,489	4,694 Added 31.37%	19,657 $1.51 Million
Q4 2019 Feb 07, 2020	BUY	$70.76 - $128.86 $262,731 - $478,457	3,713 Added 33.0%	14,963 $1.93 Million
Q3 2019 Nov 08, 2019	SELL	$77.91 - $109.6 $6,622 - $9,316	-85 Reduced 0.75%	11,250 $876,000
Q2 2019 Aug 09, 2019	BUY	$59.49 - $104.71 $674,319 - $1.19 Million	11,335 New	11,335 $0
Q4 2018 Feb 08, 2019	SELL	$32.0 - $47.43 $250,240 - $370,902	-7,820 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$47.1 - $62.7 $249,159 - $331,683	-5,290 Reduced 40.35%	7,820 $0
Q2 2018 Aug 10, 2018	BUY	$26.05 - $52.4 $339,118 - $682,143	13,018 Added 14150.0%	13,110 $0
Q3 2017 Nov 13, 2017	BUY	$4.7 - $11.7 $432 - $1,076	92	92 $0

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Account